Literature DB >> 2538292

The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.

G L Myers1, G R Cooper, C L Winn, S J Smith.   

Abstract

In collaboration with the National Heart, Lung, and Blood Institute, the CDC has supported programs for standardizing lipid measurements for more than 30 years. These programs were begun because comparable and accurate quantitative measurements were needed for epidemiologic studies of coronary heart disease. Since the first program was initiated, over 500 national and international laboratories have participated in the various CDC lipid standardization programs. The cornerstone of these standardization programs has been an accuracy base of lipid reference materials and methods developed by CDC. Specifically, CDC has developed human, serum-based reference materials for cholesterol, HDL, triglyceride, and apolipoproteins A-I and B and reference methods for total cholesterol, HDL, and triglyceride. The CDC reference method for cholesterol has been adopted as the national reference method for cholesterol by the National Reference System for the Clinical Laboratory Council of the National Committee for Clinical Laboratory Standards. The approved CDC reference method along with an approved NBS definitive method, an approved NBS certified Reference Material, and the CDC certified serum-based secondary reference materials make up the accuracy base for serum cholesterol measurements in the United States, and together they are recognized as the National Reference System for Cholesterol. The NCEP Laboratory Standardization Panel recommends that cholesterol measurements made by all clinical laboratories should be standardized so that cholesterol values are traceable to the National Reference System for Cholesterol. In support of the NCEP's efforts, CDC will establish a standardization program permitting the laboratory and manufacturing community to trace cholesterol measurements and the development of cholesterol diagnostic products back to the national reference system. The major emphasis of this standardization effort is to establish a network of reference method laboratories (1) to assign cholesterol values to all commercially prepared lots of calibrators and control materials and (2) to provide reference measurements on individual "fresh" human serum specimens to manufacturers and clinical laboratories. CDC is also working to (1) provide reference materials to manufacturers, (2) collaborate with NBS to maintain documentation of the national reference system accuracy base, (3) cooperate with proficiency testing organizations to assist in the accurate labeling of reference materials, and (4) provide training and education pertinent to cholesterol standardization.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538292

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  76 in total

1.  Cynicism: Incident diabetes and worsening of metabolic syndrome in postmenopausal women.

Authors:  Judith Wylie-Rosett; Aaron K Aragaki; Barbara Cochrane; Michael G Perri; Milagros C Rosal; Stephen R Rapp
Journal:  Diabetes Metab Syndr       Date:  2010 Oct-Dec

2.  Comparison of carotid plaque burden among healthy middle-aged men living in the US, Japan, and South Korea.

Authors:  Abhishek Vishnu; Jina Choo; Aya Kadota; Emma J M Barinas-Mitchell; Akira Fujiyoshi; Dorothy Leann Long; Takashi Hisamatsu; Vasudha Ahuja; Yasuyuki Nakamura; Rhobert W Evans; Katsuyuki Miura; Kamal H Masaki; Chol Shin; Hirotsugu Ueshima; Akira Sekikawa
Journal:  Int J Cardiol       Date:  2018-09-01       Impact factor: 4.164

3.  Meal preparation and cleanup time and cardiometabolic risk over 14 years in the Study of Women's Health Across the Nation (SWAN).

Authors:  Bradley M Appelhans; Eisuke Segawa; Imke Janssen; Lisa M Nackers; Rasa Kazlauskaite; Ana Baylin; John W Burns; Lynda H Powell; Howard M Kravitz
Journal:  Prev Med       Date:  2014-12-06       Impact factor: 4.018

4.  Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress.

Authors:  MaryFran Sowers; Daniel McConnell; Mary L Jannausch; John F Randolph; Robert Brook; Ellen B Gold; Sybil Crawford; Bill Lasley
Journal:  Clin Endocrinol (Oxf)       Date:  2007-11-02       Impact factor: 3.478

5.  Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".

Authors:  MaryFran R Sowers; John Randolph; Mary Jannausch; Bill Lasley; Elizabeth Jackson; Daniel McConnell
Journal:  Arch Intern Med       Date:  2008-10-27

6.  Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.

Authors:  Jonathan Isaacsohn; Donald Hunninghake; Helmut Schrott; Carlos A Dujovne; Robert Knopp; Stuart R Weiss; Harold Bays; John R Crouse; Michael H Davidson; Leonard M Keilson; James McKenney; Stanley G Korenman; Adrian S Dobs; Evan Stein; Ronald M Krauss; Darbie Maccubbin; Meehyung Cho; Diane J Plotkin; Yale B Mitchel
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

7.  Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?

Authors:  Karen A Matthews; Sybil L Crawford; Claudia U Chae; Susan A Everson-Rose; Mary Fran Sowers; Barbara Sternfeld; Kim Sutton-Tyrrell
Journal:  J Am Coll Cardiol       Date:  2009-12-15       Impact factor: 24.094

8.  Egg Intake Has No Adverse Association With Blood Lipids Or Glucose In Adolescent Girls.

Authors:  Melanie M Mott; Megan A McCrory; Linda G Bandini; Howard J Cabral; Stephen R Daniels; Martha R Singer; Lynn L Moore
Journal:  J Am Coll Nutr       Date:  2018-10-03       Impact factor: 3.169

9.  Interactive effects of race and depressive symptoms on calcification in African American and white women.

Authors:  Tené T Lewis; Susan A Everson-Rose; Alicia Colvin; Karen Matthews; Joyce T Bromberger; Kim Sutton-Tyrrell
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

10.  Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women.

Authors:  Edie M Goldbacher; Joyce Bromberger; Karen A Matthews
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.